Preston Klassen - 23 Mar 2023 Form 4 Insider Report for Metacrine, Inc.

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
24 Mar 2023, 12:35:32 UTC
Prior SEC filing
21 Mar 2023
Next SEC filing
12 Jun 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Preston Klassen

Key filing fact

Preston Klassen filed Form 4 for Metacrine, Inc. on 24 Mar 2023.

Key facts

  • This page summarizes Preston Klassen's Form 4 filing for Metacrine, Inc..
  • 2 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 24 Mar 2023, 12:35.

Change

  • Previous filing in this sequence was filed on 21 Mar 2023.
  • Current net transaction value: -$395,839.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MTCR transaction

Common Stock

Award

Transaction value
$395,839
Shares
-842,211
Change %
-38%
Price
$0.4700
Shares after
1,384,116
Date
23 Mar 2023
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MTCR transaction Derivative

Stock Option (right to buy)

Disposed to Issuer

Transaction value
$0
Shares
-842,211
Change %
-100%
Price
$0.000000*
Shares after
0
Date
23 Mar 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
842,211
Exercise price
$0.4700
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Fully vested

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .